1800 202 8726
Scans and what they can't tell you

Can MRI or CT Scan — Rule Out Cancer Without a Biopsy?

Imaging can find a suspicious area, but it cannot confirm whether that area is cancer, what type it is, or how to treat it. No scan — CT, MRI, or PET-CT — can rule out cancer with certainty.

Medically reviewed by Dr. Muralidhar Muddusetty, Surgical Oncologist, MBBS (AIIMS) · MS Surgery (AIIMS) · DNB Surg Onc · MRCS (Edinburgh) · Last reviewed September 2026

  • Scans show shape, not cell biology — Imaging tells you where a mass is and how large it is. It cannot tell you what the cells inside are doing.
  • A normal scan is not a clean bill of health — Small tumours, early cancers, and certain cancer types can be invisible on CT or MRI.
  • PET-CT is more sensitive, not definitive — PET-CT adds metabolic information but still cannot confirm cancer without tissue analysis.
  • The biopsy question is clinical, not financial — Whether you need one depends on your scan results and your oncologist's assessment — not on cost or convenience.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Talk to a medical oncologist

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

MRI and CT scans can find suspicious areas, but they cannot confirm cancer, identify its type, or guide treatment. No imaging test can rule out cancer with certainty. A biopsy is the only definitive answer. Your oncologist will tell you when one is necessary.

What can each test actually tell you?

What you want to knowCT or MRIPET-CTBiopsy
Is there a suspicious area?Often — shows size and locationOften — also shows metabolic activityNot used to find — used to confirm
Does it confirm cancer?NoNoYes — the only definitive test
Does it show the cancer type?NoNoYes — cell analysis in the laboratory
Can it rule out cancer?Not with certainty — small and early cancers can be missedNot with certainty — very early lesions may not show activityNot applicable
Can it guide treatment choices?Partly — shows spread and organ involvementPartly — useful for staging and response assessmentYes — molecular testing can be done on the sample

Where does imaging miss cancer?

Some cancers are invisible on CT and MRI. Early breast cancer, very small lymph node deposits, carcinoma in situ, and diffuse spread through the abdomen can all be present on a scan that looks entirely normal.

Imaging shows the shape of tissue, not what individual cells are doing. A mass that looks benign on a scan can be malignant. Some cancers produce no visible mass at all.

PET-CT adds information about metabolic activity and is more sensitive for some cancer types. But infections and inflammation can produce the same appearance on a PET scan — which is why a positive PET finding still requires tissue confirmation before treatment begins.

Not sure what this means for you?

Share your reports and a senior oncologist will explain your options in plain language — no obligation to start treatment.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

You do not have to work this out alone

A 45-minute consultation with a specialist who treats this every week.

Book Free Consultation Call 1800 202 8726

When is a biopsy unavoidable?

  • The scan shows a mass or suspicious area — a confirmed diagnosis is needed before treatment can start.
  • The scan is normal but symptoms or blood tests point strongly to cancer — imaging can be falsely reassuring.
  • You have a known cancer and a new area has appeared — it may be a metastasis or a second cancer, and treatment depends on which.
  • The likely cancer type has more than one treatment option — the choice between them requires knowing what is in the tissue.
  • Molecular testing is needed — biomarkers that determine eligibility for targeted therapy or immunotherapy can only be measured on tissue.
  • The team needs to confirm a suspected recurrence before restarting or changing treatment.

Questions families ask before agreeing to a biopsy

Can we wait and repeat the scan in a few months instead?

Watchful waiting with repeat imaging is appropriate in some specific situations — such as a very small lung nodule with certain characteristics, where NCCN and ESMO guidelines allow interval scanning. This is a clinical decision based on the lesion's size, features, and your risk profile. It is not a general alternative to biopsy when a diagnosis is needed before treatment can start. Ask your oncologist whether watchful waiting is supported by guidance for your specific finding, and what the plan is if the next scan shows growth.

What if the biopsy site is too deep or difficult to reach?

Image-guided biopsy allows tissue to be taken from sites that would previously have required surgery — including deep lymph nodes, liver lesions, and lung masses — using CT or ultrasound guidance, performed by an interventional radiologist. It is not always possible, and occasionally a surgical biopsy is needed instead. Your team will tell you which approach is available for your specific lesion and what the risks of each are.

Could a biopsy cause the cancer to spread?

This fear is understandable and comes up often. The concern that a needle biopsy spreads cancer cells along its track has been studied carefully. For the vast majority of cancer types and biopsy techniques used in routine practice, the evidence does not support this as a meaningful clinical risk. ASCO and ESMO guidelines continue to recommend biopsy as the required diagnostic step. If you have a concern about your specific cancer type, ask your oncologist what the evidence shows for your situation.

Why do I need a biopsy when the scan already shows cancer has spread?

Even when imaging shows widespread disease, the cancer type, grade, and molecular profile determine which treatment is appropriate. The same pattern on a scan can be lung cancer, lymphoma, or a cancer that started elsewhere — and these are treated in fundamentally different ways. Molecular markers measured on the biopsy sample may also show whether targeted therapy or immunotherapy is an option. The scan shows that something is there. The biopsy tells you what to do about it.

Did you know?

High metabolic activity on a PET-CT scan — the feature that makes it useful for detecting cancer — is also produced by infections, inflammatory conditions, and recent surgery sites. This is why ASCO and ESMO guidelines require tissue confirmation before treatment is started on the basis of imaging alone.

Imaging finds it. The biopsy names it.

Source: ASCO and ESMO guidelines on diagnostic workup and tissue confirmation

Explore 71 more Understanding Your Biopsy and Whether You Need One topics

HUB — Does a Biopsy Spread Cancer? Myths and Evidence

HUB — What Is a Biopsy? Everything You Need to Know

All Understanding Your Biopsy and Whether You Need One →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Can a PET-CT scan confirm cancer without a biopsy?

PET-CT detects areas of high metabolic activity, which is often elevated in cancer cells. But infections, inflammatory conditions, and post-surgical changes can look identical on a PET scan. A PET-CT finding is suspicious, not diagnostic. ASCO and ESMO guidelines require tissue confirmation before treatment decisions are made on imaging alone. There are narrow, protocol-defined exceptions — your oncologist will tell you if your situation is one of them.

What does it mean when the radiologist says the scan is 'suspicious'?

'Suspicious' means the finding has features that could indicate cancer, but imaging cannot confirm it. It is the radiologist's honest way of naming the limit of what the scan can tell you — not a diagnosis. It is a signal to your oncologist that further evaluation is needed to answer the question. Your treating team will decide what step comes next, and that decision may well include a biopsy.

Are there any cancers that are diagnosed without a biopsy?

In a small number of situations a diagnosis may be made without tissue — for example, some liver cancers with a characteristic appearance on multiphasic CT in a patient with known cirrhosis, or certain blood cancers where laboratory findings together meet defined diagnostic criteria. These are specific, protocol-defined exceptions, not a general rule. If a biopsy is being recommended to you, it is because these exceptions do not apply in your situation.

How accurate is MRI at detecting cancer?

MRI accuracy varies considerably by cancer type and body site. It is highly sensitive for some cancers in specific locations and less reliable for others. No imaging achieves perfect sensitivity or specificity. A normal MRI reduces the probability of cancer being present, but does not eliminate it. The accuracy of your specific scan in your specific situation is a question for your radiologist or oncologist — not a general figure that applies across all cancers.

Can liquid biopsy replace a tissue biopsy?

Liquid biopsy — testing blood for fragments of tumour DNA — is used in specific clinical situations, such as monitoring for recurrence or detecting resistance mutations in cancers already diagnosed by tissue. It is not yet a replacement for tissue biopsy as the initial diagnostic step. NCCN and ESMO guidance on where liquid biopsy is appropriate continues to evolve. Ask your oncologist whether it is relevant to your situation and at what stage of your care.

What should I ask my oncologist before agreeing to a biopsy?

Ask three things: what is being confirmed, and what will the result change about treatment? What type of biopsy is planned and what are the risks? What happens if the result is inconclusive? A clear answer to all three helps you understand why the procedure is being recommended and what it is expected to achieve. Write the answers down — these conversations are hard to remember afterwards. A biopsy is not something to navigate around; it is the step that makes treatment possible.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation